45. Heart Failure 💔 Internal Medicine (Harrison-Based) | USMLE Step 2 CK | Dr Maithreyi Govind

📌𝗝𝗼𝗶𝗻 𝗢𝘂𝗿 𝗧𝗲𝗹𝗲𝗴𝗿𝗮𝗺 𝗖𝗵𝗮𝗻𝗻𝗲𝗹 𝗛𝗲𝗿𝗲:-https://t.me/conceptualmedicine009 📌 𝐅𝐨𝐥𝐥𝐨𝐰 𝐨𝐧 𝐈𝐧𝐬𝐭𝐚𝐠𝐫𝐚𝐦:- https://www.instagram.com/conceptual_... Heart Failure 💔 Internal Medicine (Harrison-Based) | USMLE Step 2 CK | Dr Maithreyi Govind Heart failure (HF) is a complex clinical syndrome resulting from structural or functional impairment of ventricular filling or ejection of blood, leading to inadequate cardiac output to meet tissue demands. It remains one of the most important high-yield internal medicine topics for USMLE Step 2 CK, particularly in inpatient settings and chronic disease management. According to Harrison’s Principles of Internal Medicine, HF is categorized into heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF). HFrEF (EF less than 40%) is characterized by systolic dysfunction, often due to ischemic heart disease, hypertension, or dilated cardiomyopathy, while HFpEF (EF greater than or equal to 50%) involves diastolic dysfunction, typically from long-standing hypertension, obesity, aging, or restrictive cardiomyopathies. Clinical features include dyspnea on exertion, orthopnea, paroxysmal nocturnal dyspnea (PND), fatigue, peripheral edema, and jugular venous distention (JVD). On auscultation, one may hear an S3 gallop in HFrEF and S4 in HFpEF. Additional signs include bibasilar crackles, hepatojugular reflux, and displaced apical impulse. Diagnosis begins with clinical suspicion, supported by chest X-ray (showing pulmonary congestion or cardiomegaly), ECG, BNP or NT-proBNP levels, and most importantly, echocardiography to assess ejection fraction and structural abnormalities. Laboratory evaluation should assess for precipitating factors such as anemia, thyroid dysfunction, renal insufficiency, and ischemia. Management of HFrEF includes guideline-directed medical therapy (GDMT) with drugs that improve survival and reduce hospitalizations: ACE inhibitors or ARBs (or ARNI like sacubitril/valsartan) Beta-blockers (carvedilol, bisoprolol, metoprolol succinate) Mineralocorticoid receptor antagonists (e.g., spironolactone) SGLT2 inhibitors (e.g., dapagliflozin, empagliflozin) Loop diuretics (e.g., furosemide) provide symptomatic relief for volume overload. Additional options include hydralazine + nitrates (especially in African American patients), ICDs, and CRT in selected cases. HFpEF management focuses on controlling comorbidities (hypertension, atrial fibrillation, diabetes), diuresis for congestion, and lifestyle interventions; no therapy to date has definitively shown mortality benefit. Acute decompensated heart failure (ADHF) requires hospitalization, IV loop diuretics, oxygen, and close hemodynamic monitoring. Identification and treatment of triggers (ischemia, arrhythmia, infection, medication nonadherence) is essential. On USMLE Step 2 CK, expect questions on clinical features, echo findings, BNP interpretation, drug mechanisms, and recognizing indications for devices or transplant referral. Also focus on differentiating HFrEF from HFpEF, knowing which therapies reduce mortality, and recognizing classic complications like pulmonary edema, cardiogenic shock, and arrhythmias. #HeartFailure #HFrEF #HFpEF #USMLEStep2CK #InternalMedicine #HarrisonsBased #BNP #Echocardiography #LoopDiuretics #SGLT2Inhibitors #ARNI #CardiologyBuzzwords #ADHF #MedicalEducation #Step2Review #WhiteboardMedicine #DrMaithreyiGovind #USMLEBuzzwords #MCQPrep #USMLE2025 #CRT #ICD #HeartFailureManagement #PulmonaryEdema #JVD #Orthopnea #ParoxysmalNocturnalDyspnea #CardiacDecompensation #MedStudentLife #ConceptualMedicine #MedicalConcepts #NEETPGPrep #FMGE2025 #USMLE2025 #ClinicalMedicine #MBBSConcepts #NextExamPrep #MedSchoolMadeEasy #MedStudentLife #HighYieldMedicine #PathophysiologySimplified #LearnMedicineFast #VisualMedicine #MedicalMnemonics #CrackNEETPG #USMLEStep1Prep #MedEducationRevolution #MBBSShorts #DoctorInTheMaking